Sauer Torill, Ebeltoft Kristin, Pedersen Mette Kristin, Kåresen Rolf
Department of Pathology, Oslo University Hospital, N-0424 Oslo, Norway.
Cytojournal. 2010 Dec 31;7:24. doi: 10.4103/1742-6413.75665.
Estrogen receptor (ER) status and progesterone receptor (PgR) status are strong prognostic and predictive markers in breast carcinomas. Steroid receptors are fragile and optimal handling of both cytological and histological material, including fixation, is crucial. Liquid based material offers the possibility to prepare a number of slides from one lesion and is increasingly being used for immunocytochemistry. It also offers the possibility to prepare several smears and to store these at different temperatures as well as storing residual material in the liquid.
The samples consisted of fine needle aspirate material from 53 breast carcinomas. Direct smears and liquid based preparations were used in parallel for immunocytochemical detection of ER and PgR receptor status. Slides from liquid suspensions were stored at -20°C and -74°C for 3 and 6 months, respectively. Direct smears were fixed primarily in 4% formalin. Liquid based specimens were post-fixed in 4% formalin. All specimens were subjected to microwave-stimulated epitope retrieval. Antibody concentrations were ER 1:150 and PgR 1:200 for both preparation methods. The immunostaining program was identical for both the methods.
Liquid based specimens had a statistically non-significant higher percentage of positive cases compared to direct smears. Specimens prepared from liquid suspensions and stored at -20°C and -74°C for 3 and 6 months, respectively, showed a virtually unchanged ER and PgR reactivity (P = 0.002).
Liquid suspensions and liquid based slide preparations seem to offer an optimal pre-fixation and preservation of ER/PgR in breast carcinoma cells. Post-fixation with 4% formalin followed by microwave-stimulated epitope retrieval before immunostaining is recommended. Long-time storage of liquid based specimens at -20°C or -74°C for at least 6 months without significant loss of immunoreactivity is feasible. They may be used as internal positive and negative controls.
雌激素受体(ER)状态和孕激素受体(PgR)状态是乳腺癌中强有力的预后和预测标志物。类固醇受体很脆弱,对细胞学和组织学材料进行包括固定在内的最佳处理至关重要。液基材料提供了从一个病变制备多张玻片的可能性,并且越来越多地用于免疫细胞化学。它还提供了制备多张涂片并在不同温度下储存这些涂片以及将剩余材料储存在液体中的可能性。
样本包括53例乳腺癌的细针穿刺抽吸材料。直接涂片和液基制剂并行用于ER和PgR受体状态的免疫细胞化学检测。来自液体悬液的玻片分别在-20°C和-74°C下储存3个月和6个月。直接涂片主要固定在4%福尔马林中。液基标本用4%福尔马林后固定。所有标本均进行微波刺激抗原修复。两种制备方法的抗体浓度均为ER 1:150和PgR 1:200。两种方法的免疫染色程序相同。
与直接涂片相比,液基标本的阳性病例百分比在统计学上无显著差异。分别从液体悬液制备并在-20°C和-74°C下储存3个月和6个月的标本显示ER和PgR反应性几乎未变(P = 0.002)。
液体悬液和液基玻片制剂似乎为乳腺癌细胞中ER/PgR提供了最佳的固定前处理和保存。建议在免疫染色前先用4%福尔马林后固定,然后进行微波刺激抗原修复。将液基标本在-20°C或-74°C下长时间储存至少6个月而免疫反应性无明显损失是可行的。它们可作为内部阳性和阴性对照。